• Acta radiologica · Feb 2010

    Comparative Study

    Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.

    • Biao Huang, Chang-Hong Liang, Hong-Jun Liu, Guang-Yi Wang, and Shui-Xing Zhang.
    • Department of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China. cjr.huangbiao@vip.163.com
    • Acta Radiol. 2010 Feb 1; 51 (1): 78-84.

    BackgroundLesion-to-brain contrast after gadolinium administration is significantly higher at 3.0 Tesla (T) compared to 1.5 T. The high in vivo relaxivity of gadobenate dimeglumine (Gd-BOPTA) may permit the use of lower-dose contrast agents.PurposeTo investigate whether low-dose contrast-enhanced MRI at 3.0 T using a high-relaxivity contrast agent (Gd-BOPTA) can achieve a comparable or improved contrast-to-noise ratio (CNR) for the detection of brain metastases compared with examination of the same patient at 1.5 T using a standard dose of gadopentetate dimeglumine (Gd-DTPA).Material And MethodsA total of 18 patients with known brain metastases were first imaged at 1.5 T with 0.1 mmol/kg Gd-DTPA. Patients returned at least 24 hours later for imaging at 3.0 T with Gd-BOPTA at cumulative doses of 0.025 mmol/kg, 0.05 mmol/kg, 0.075 mmol/kg, and 0.1 mmol/kg (0.1 mmol/kg body weight overall). The CNR of enhancing brain lesions compared to the normal contralateral white matter was calculated. For the 3.0 T study using different cumulative doses of Gd-BOPTA, the CNR of lesions was compared with CNR of the same lesions imaged at 1.5 T using 0.1 mmol/kg Gd-DTPA, by using the Wilcoxon matched-pairs signed-rank test.ResultsAt 1.5 T with 0.1 mmol/kg Gd-DTPA, the mean CNR between enhanced lesions and cerebral white matter was 12.01 +/- 2.53. With 3.0 T imaging using different cumulative doses of Gd-BOPTA, the mean CNRs were 7.19 +/- 4.06, 15.31 +/- 6.37, 25.44 +/- 11.02, and 31.88 +/- 13.21. At 3.0 T with 0.05 mmol/kg Gd-BOPTA, CNR was 1.34-fold higher compared to CNR at 1.5 T with 0.1 mmol/kg Gd-DTPA (P <0.01).ConclusionComparable contrast enhancement of brain metastases can be achieved with a 0.05-mmol/kg dose of Gd-BOPTA at 3.0 T compared to imaging at 1.5 T using 0.1 mmol/kg Gd-DTPA.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.